Citation: Mh. Devries et al., IDENTIFICATION OF THE CYTOCHROMES P450 INVOLVED IN THE METABOLISM OF FLESINOXAN - IN-VITRO IN-VIVO CORRELATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 1-1
Citation: Pcm. Vandekerkhof et al., A LONG-TERM ASSESSMENT OF THE SAFETY AND TOLERABILITY OF CALCITRIOL OINTMENT IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS, Journal of dermatological treatment, 7, 1996, pp. 11-14
Citation: J. Vanharten et al., TOXICOKINETICS AND CLINICAL KINETICS OF TOPICALLY APPLIED VITAMIN-D ANALOGS, Journal of dermatological treatment, 7, 1996, pp. 19-21
Citation: C. Baedeker et J. Vanharten, INFLUENCE OF FLESINOXAN ON IN-VIVO HEPATIC-METABOLISM - A COCKTAIL STUDY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 152-152
Citation: J. Vanharten, PLASMA-CONCENTRATIONS OF CALCITRIOL IN PSORIASIS PATIENTS TREATED WITH CALCITRIOL OINTMENT, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 197-197
Authors:
DEVRIES MH
VANHARTEN J
VANBEMMEL P
RAGHOEBAR M
Citation: Mh. Devries et al., PHARMACOKINETICS OF FLUVOXAMINE MALEATE AFTER INCREASING SINGLE ORAL DOSES IN HEALTHY-SUBJECTS, Biopharmaceutics & drug disposition, 14(4), 1993, pp. 291-296